Skip to main content

About Ariel Perez Perez

Ariel Perez Perez, M.D., is a hematologist and medical oncologist at Miami Cancer Institute. Dr. Perez Perez specializes in bone marrow transplant, cellular immunotherapy and malignant hematology. He is fluent in English and Spanish. Dr. Perez Perez joined Miami Cancer Institute from the H. Lee Moffitt Cancer Center & Research Institute in Tampa, where he completed a fellowship in bone marrow transplant and cellular immunotherapy. During his fellowship, he was involved in clinical research in CAR T-cell therapy for patients with relapsed refractory B-cell lymphomas. He served as chief resident and chief fellow during his residency and fellowship programs. Dr. Perez Perez earned several academic achievement awards, including the Internal Medicine and Hematology-Oncology Academic Achievement Awards at Orlando Health. He also graduated medical school with honors (Summa Cum Laude). Dr. Perez Perez’s research has been published in peer-reviewed publications, including the Transplantation and Cellular Therapy Journal, Journal of Clinical Oncology, Journal of Thoracic Oncology and Annals of Oncology. He has also presented his research at numerous research meetings, industry conferences and events. Dr. Perez Perez’s approach to patient care is to establish and maintain communication and trust with his patients while providing the highest level of evidence-based medical care.

Positions

July 2021 - Present Hematologist/Medical Oncologist, Baptist Health South Florida ‐ Baptist Health Medical Group Oncology, LLC Miami, FL
to
May 2011 - May 2012 Resident, National Institute of Oncology and Radiobiology, Havana, Cuba ‐ Medical Oncology Department and Clinical Trial Unit
to

Disciplines

Research Interests

Grants

2021 - 2024 A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults with Systemic Lupus Erythematosus
Pharnext SA - NCT04762758
Role: Researcher
Colleague(s): Maria Saporta
2020 - 2023 A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults with Systemic Lupus Erythematosus
Eli Lilly and Company / Nektar Therapeutics - NCT04433585
Role: Researcher
Colleague(s): Maria Carpintero
2011 - 2012 Design and conduction of early phase clinical trials in hematological and non-hematological malignancies
National Institute of Oncology and Radiobiology
Role: Junior Researcher
Colleague(s): Elias Gracia
$
to
Enter a valid date range.

Professional Service and Affiliations

2021 - Present Baptist Health Medical Group Oncology, Miami Cancer Institute. Miami, FL
2017 - Present Member, American Society of Clinical Oncology
2017 - Present Member, American Society of Hematology
2014 - Present Member, American College of Physicians
2020 - 2021 Moffitt Cancer Center. Tampa, FL., Bone Marrow Transplant and Cellular Immunotherapy Fellowship
2017 - 2020 UF Health Cancer Center at Orlando Health, Orlando, FL.. Hematology Oncology Fellowship. Program director: Dr. Said Baidas
2014 - 2017 Orlando Health. Orlando, FL., Internal Medicine Residency. Program director: Dr. Mario Madruga
2011 - 2012 National Institute of Oncology and Radiobiology. Havana, Cuba, Member of the Medical Oncology Department and Clinical Trial Unit. Department Chief: Dr. Elias Graci
2009 - 2012 Member, Cuban Scientific Society of Oncology, Radiotherapy and Nuclear Medicine
2009 - 2011 Member, American Association for Cancer Research
to
Enter a valid date range.

Honors and Awards

  • 2004 Award for Academic Achievement. University of Medical Sciences, Havana, Cuba
  • 2011 Award for Academic Achievement. National Institute of Oncology and Radiobiology
  • 2014-2016 Annual In-Training Examination Award. Orlando Health, Internal Medicine Program
  • 2015 ACP Medical Jeopardy Florida State Champion
  • 2016 ACP Medical Jeopardy International Championship Top 20 Battle Rounds
  • 2017 Award for Academic Achievement. Orlando Health, Internal Medicine Program
  • 2018-2020 Annual In-Training Examination Award. Orlando Health, Hematology Oncology Fellowship Program

Courses

  • 09/2004 - 01/2007: Family Medicine. M.D. Residency University of Medical Sciences. Havana, Cuba. Program director: Dr. Angel L. Selva
  • 04/2007 - 05/2011: Oncology (Internal Medicine) M.D. Fellowship, Chief Resident 2010-2011. National Institute of Oncology and Radiobiology. Havana, Cuba. Program director: Dr. Nelido Gonzalez
  • 07/2014 - 06/2017: Internal Medicine M.D. Residency, Chief Resident 2016-2017. Orlando Health. Orlando, FL. Program director: Dr. Mario Madruga
  • 2017-2020 Hematology Oncology Fellowship, Chief Fellow 2019-2020. UF Health Cancer Center at Orlando Health. Orlando, FL. Program director: Dr. Said Baidas
  • 2020 Current Bone Marrow Transplant and Cellular Immunotherapy Fellowship. Program director: Dr. Farhad Khimani

Education

to
2021 - Present Fellowship, Moffitt Cancer Center, Tampa, FL
to
July 2017 - June 2020 Fellowship, US Health Cancer Center at Orlando Health, Orlando, FL ‐ Hematology Oncology
to
July 2014 - June 2017 Resident, Orlando Health, Orlando, FL ‐ Internal Medicine
to
April 2007 - May 2011 Resident, National Institute of Oncology and Radiobiology, Havana, Cuba
to
September 2004 - January 2007 Resident, University of Medical Sciences, Havana, Cuba ‐ Family Medicine
to
September 1998 - July 2004 Doctor in Medicine, University of Medical Sciences. Havana Cuba
to
September 1994 - July 1997 Bachelor in Sciences, IPVCE Vladimir I Lenin
to

Links

Contact Information

Miami Cancer Institute
8900 N. Kendall Drive
Miami, FL 33176
Phone: 786-596-2000

Articles (17)

Abstracts (1)

Posters (5)

Presentations (1)